UBS Group
DRIOW

UBS Group’s DarioHealth Corp. Warrant DRIOW Stock Holding History

UBS Group’s Portfolio DRIOW Stock Details DRIOW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-506
Closed – – 9889
2020
Q4 		$0 Buy
506
+340
+205% +$21 ﹤0.01% 9050
2020
Q3 		$0 Sell
166
-6,635
-98% -$671 ﹤0.01% 8698
2020
Q2 		$1K Sell
6,801
-1,629
-19% -$55 ﹤0.01% 7870
2020
Q1 		$0 Buy
8,430
+4,120
+96% +$129 ﹤0.01% 8673
2019
Q4 		$0 Sell
4,310
-2,607
-38% -$59 ﹤0.01% 8599
2019
Q3 		$0 Sell
6,917
-800
-10% -$34 ﹤0.01% 8436
2019
Q2 		$0 Buy
7,717
+95
+1% +$3 ﹤0.01% 8341
2019
Q1 		$0 Hold
7,622
– – ﹤0.01% 8408
2018
Q4 		$0 Sell
7,622
-9,900
-57% -$1.16K ﹤0.01% 8467
2018
Q3 		$2K Hold
17,522
– – ﹤0.01% 7782
2018
Q2 		$2K Buy
17,522
+2,393
+16% +$588 ﹤0.01% 7766
2018
Q1 		$3K Buy
15,129
+9,800
+184% +$2.67K ﹤0.01% 7471
2017
Q4 		$1K Buy
5,329
+700
+15% +$191 ﹤0.01% 7751
2017
Q3 		$1K Buy
4,629
+4,229
+1,057% +$1.22K ﹤0.01% 7619
2017
Q2 		$0 Hold
400
– – ﹤0.01% 8143
2017
Q1 		$0 Buy
400
+200
+100% +$144 ﹤0.01% 8142
2016
Q4 		$0 Buy
+200
New +$134 ﹤0.01% 8166

UBS Group's DRIOW Position: Q1 2021 in Review

UBS Group sold out of DarioHealth Corp. Warrant (DRIOW) in Q1 2021, closing a stake of 506 shares.

UBS Group first reported a position in DRIOW in Q4 2016 and held it in 17 quarters. The position peaked at $3K in Q1 2018. 0 funds tracked by Wall St. Rank hold DRIOW as of Q1 2021.

  • UBS Group reported no remaining DarioHealth Corp. Warrant position as of Q1 2021 after selling out during the quarter.
  • UBS Group sold 506 DarioHealth Corp. Warrant shares in Q1 2021.
  • UBS Group first reported a position in DarioHealth Corp. Warrant in Q4 2016 and held it in 17 quarters.
  • UBS Group's DarioHealth Corp. Warrant position peaked at $3K in Q1 2018.
  • 0 funds tracked by Wall St. Rank held DarioHealth Corp. Warrant as of Q1 2021.

Based on UBS Group's 13F filing for Q1 2021, filed 12 May 2021.